A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/22 (2006.01) A61K 38/04 (2006.01) A61K 38/55 (2006.01)
Patent
CA 2119019
2119019 9305809 PCTABS00021 Treatment or prevention of myointimal proliferation in atherosclerosis, restenosis induced by angioplasty or vascular reconstructive surgery, glomerulonephritis, glomerulosclerosis or other diseases involving vascular cell proliferation, with a natriuretic peptide or a neutral endopeptidase inhibitor such as N-[N-[(L)-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl]-2-phenylethyl_ ]-L-phenylalanyl]-.beta.-alanine and N-[2-mercaptomethyl-3-(2-methylphenyl)propionyl]-methionine, or with a neutral endopeptidase inhibitor in combination with a natriuretic peptide or an angiotensin converting enzyme inhibitor are disclosed.
Davis Harry R.
Sybertz Edmund J.
Schering Corporation
Swabey Ogilvy Renault
LandOfFree
Pharmaceutical compositions comprising natriuretic peptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising natriuretic peptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising natriuretic peptides... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1417309